Last reviewed · How we verify

NCT07262775

Radicle Relief RAL™: A Study Assessing the Impact of Health and Wellness Products on Pain Relief and Related Health Outcomes

Not yet recruiting NA Last updated 4 December 2025
What this trial tests

NA trial testing Pain Relief Supplement Product Placebo Control in Pain Interference in 715 participants. Not yet recruiting.

Timeline
4 January 2026
Primary endpoint
4 January 2027
4 January 2027

Quick facts

Lead sponsorRadicle Science
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment715
Start date4 January 2026
Primary completion4 January 2027
Estimated completion4 January 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Radicle Science — full company profile →

Who can join

Adults 21 to 105, any sex, with Pain Interference. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radicle Relief RAL: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on pain relief and related health outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Radicle Science trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07262775.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing